Selected research
Industry Research
Hypnotic Sleep Aid Industry Research Report 2026
Market perspective
The global Hypnotic Sleep Aid market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Hypnotic Sleep Aid is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Hypnotic Sleep Aid is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Hypnotic Sleep Aid is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Hypnotic Sleep Aid include Takeda Pharmaceuticals, Eisai Co., Ltd., Sanofi, Merck & Co., Pfizer, GlaxoSmithKline (GSK), Torrent Pharmaceuticals, Teva Pharmaceuticals and Sunovion Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Hypnotic Sleep Aid market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Hypnotic Sleep Aid Market by Company
Takeda Pharmaceuticals
Eisai Co., Ltd.
Sanofi
Merck & Co.
Pfizer
GlaxoSmithKline (GSK)
Torrent Pharmaceuticals
Teva Pharmaceuticals
Sunovion Pharmaceuticals
Sandoz
Perrigo Company
Mylan N.V.
Mallinckrodt Pharmaceuticals
Johnson & Johnson
Endo Pharmaceuticals
Cadila Healthcare (Zydus Cadila)
Apotex
Alvogen
Alembic Pharmaceuticals
Actavis
Hypnotic Sleep Aid Segment by Type
Prescription Drugs
Over-the-Counter Drugs
Natural Supplements
Hypnotic Sleep Aid Segment by Application
Hospital
Pharmacy
Other
Hypnotic Sleep Aid Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hypnotic Sleep Aid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hypnotic Sleep Aid and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hypnotic Sleep Aid.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Hypnotic Sleep Aid manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Hypnotic Sleep Aid by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Hypnotic Sleep Aid in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Prescription Drugs
- Over-the-Counter Drugs
- Natural Supplements
Applications
- Hospital
- Pharmacy
- Other
Companies covered
- Takeda Pharmaceuticals
- Eisai Co., Ltd.
- Sanofi
- Merck & Co.
- Pfizer
- GlaxoSmithKline (GSK)
- Torrent Pharmaceuticals
- Teva Pharmaceuticals
- Sunovion Pharmaceuticals
- Sandoz
- Perrigo Company
- Mylan N.V.
- Mallinckrodt Pharmaceuticals
- Johnson & Johnson
- Endo Pharmaceuticals
- Cadila Healthcare (Zydus Cadila)
- Apotex
- Alvogen
- Alembic Pharmaceuticals
- Actavis
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Hypnotic Sleep Aid Market Size (2021-2032)
- 2.2.2 Global Hypnotic Sleep Aid Sales (2021-2032)
- 2.2.3 Global Hypnotic Sleep Aid Market Average Price (2021-2032)
- 2.3 Hypnotic Sleep Aid by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Prescription Drugs
- 2.3.3 Over-the-Counter Drugs
- 2.3.4 Natural Supplements
- 2.4 Hypnotic Sleep Aid by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Pharmacy
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Hypnotic Sleep Aid Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Hypnotic Sleep Aid Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Hypnotic Sleep Aid Revenue of Manufacturers (2021-2026)
- 3.4 Global Hypnotic Sleep Aid Average Price by Manufacturers (2021-2026)
- 3.5 Global Hypnotic Sleep Aid Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Hypnotic Sleep Aid, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Hypnotic Sleep Aid, Product Type & Application
- 3.8 Global Manufacturers of Hypnotic Sleep Aid, Established Date
- 3.9 Global Hypnotic Sleep Aid Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Takeda Pharmaceuticals
- 4.1.1 Takeda Pharmaceuticals Company Information
- 4.1.2 Takeda Pharmaceuticals Business Overview
- 4.1.3 Takeda Pharmaceuticals Hypnotic Sleep Aid Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Takeda Pharmaceuticals Hypnotic Sleep Aid Product Portfolio
- 4.1.5 Takeda Pharmaceuticals Recent Developments
- 4.2 Eisai Co., Ltd.
- 4.2.1 Eisai Co., Ltd. Company Information
- 4.2.2 Eisai Co., Ltd. Business Overview
- 4.2.3 Eisai Co., Ltd. Hypnotic Sleep Aid Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Eisai Co., Ltd. Hypnotic Sleep Aid Product Portfolio
- 4.2.5 Eisai Co., Ltd. Recent Developments
- 4.3 Sanofi
- 4.3.1 Sanofi Company Information
- 4.3.2 Sanofi Business Overview
- 4.3.3 Sanofi Hypnotic Sleep Aid Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sanofi Hypnotic Sleep Aid Product Portfolio
- 4.3.5 Sanofi Recent Developments
- 4.4 Merck & Co.
- 4.4.1 Merck & Co. Company Information
- 4.4.2 Merck & Co. Business Overview
- 4.4.3 Merck & Co. Hypnotic Sleep Aid Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Merck & Co. Hypnotic Sleep Aid Product Portfolio
- 4.4.5 Merck & Co. Recent Developments
- 4.5 Pfizer
- 4.5.1 Pfizer Company Information
- 4.5.2 Pfizer Business Overview
- 4.5.3 Pfizer Hypnotic Sleep Aid Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Pfizer Hypnotic Sleep Aid Product Portfolio
- 4.5.5 Pfizer Recent Developments
- 4.6 GlaxoSmithKline (GSK)
- 4.6.1 GlaxoSmithKline (GSK) Company Information
- 4.6.2 GlaxoSmithKline (GSK) Business Overview
- 4.6.3 GlaxoSmithKline (GSK) Hypnotic Sleep Aid Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 GlaxoSmithKline (GSK) Hypnotic Sleep Aid Product Portfolio
- 4.6.5 GlaxoSmithKline (GSK) Recent Developments
- 4.7 Torrent Pharmaceuticals
- 4.7.1 Torrent Pharmaceuticals Company Information
- 4.7.2 Torrent Pharmaceuticals Business Overview
- 4.7.3 Torrent Pharmaceuticals Hypnotic Sleep Aid Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Torrent Pharmaceuticals Hypnotic Sleep Aid Product Portfolio
- 4.7.5 Torrent Pharmaceuticals Recent Developments
- 4.8 Teva Pharmaceuticals
- 4.8.1 Teva Pharmaceuticals Company Information
- 4.8.2 Teva Pharmaceuticals Business Overview
- 4.8.3 Teva Pharmaceuticals Hypnotic Sleep Aid Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Teva Pharmaceuticals Hypnotic Sleep Aid Product Portfolio
- 4.8.5 Teva Pharmaceuticals Recent Developments
- 4.9 Sunovion Pharmaceuticals
- 4.9.1 Sunovion Pharmaceuticals Company Information
- 4.9.2 Sunovion Pharmaceuticals Business Overview
- 4.9.3 Sunovion Pharmaceuticals Hypnotic Sleep Aid Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Sunovion Pharmaceuticals Hypnotic Sleep Aid Product Portfolio
- 4.9.5 Sunovion Pharmaceuticals Recent Developments
- 4.10 Sandoz
- 4.10.1 Sandoz Company Information
- 4.10.2 Sandoz Business Overview
- 4.10.3 Sandoz Hypnotic Sleep Aid Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Sandoz Hypnotic Sleep Aid Product Portfolio
- 4.10.5 Sandoz Recent Developments
- 4.11 Perrigo Company
- 4.11.1 Perrigo Company Company Information
- 4.11.2 Perrigo Company Business Overview
- 4.11.3 Perrigo Company Hypnotic Sleep Aid Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Perrigo Company Hypnotic Sleep Aid Product Portfolio
- 4.11.5 Perrigo Company Recent Developments
- 4.12 Mylan N.V.
- 4.12.1 Mylan N.V. Company Information
- 4.12.2 Mylan N.V. Business Overview
- 4.12.3 Mylan N.V. Hypnotic Sleep Aid Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Mylan N.V. Hypnotic Sleep Aid Product Portfolio
- 4.12.5 Mylan N.V. Recent Developments
- 4.13 Mallinckrodt Pharmaceuticals
- 4.13.1 Mallinckrodt Pharmaceuticals Company Information
- 4.13.2 Mallinckrodt Pharmaceuticals Business Overview
- 4.13.3 Mallinckrodt Pharmaceuticals Hypnotic Sleep Aid Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Mallinckrodt Pharmaceuticals Hypnotic Sleep Aid Product Portfolio
- 4.13.5 Mallinckrodt Pharmaceuticals Recent Developments
- 4.14 Johnson & Johnson
- 4.14.1 Johnson & Johnson Company Information
- 4.14.2 Johnson & Johnson Business Overview
- 4.14.3 Johnson & Johnson Hypnotic Sleep Aid Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Johnson & Johnson Hypnotic Sleep Aid Product Portfolio
- 4.14.5 Johnson & Johnson Recent Developments
- 4.15 Endo Pharmaceuticals
- 4.15.1 Endo Pharmaceuticals Company Information
- 4.15.2 Endo Pharmaceuticals Business Overview
- 4.15.3 Endo Pharmaceuticals Hypnotic Sleep Aid Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Endo Pharmaceuticals Hypnotic Sleep Aid Product Portfolio
- 4.15.5 Endo Pharmaceuticals Recent Developments
- 4.16 Cadila Healthcare (Zydus Cadila)
- 4.16.1 Cadila Healthcare (Zydus Cadila) Company Information
- 4.16.2 Cadila Healthcare (Zydus Cadila) Business Overview
- 4.16.3 Cadila Healthcare (Zydus Cadila) Hypnotic Sleep Aid Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Cadila Healthcare (Zydus Cadila) Hypnotic Sleep Aid Product Portfolio
- 4.16.5 Cadila Healthcare (Zydus Cadila) Recent Developments
- 4.17 Apotex
- 4.17.1 Apotex Company Information
- 4.17.2 Apotex Business Overview
- 4.17.3 Apotex Hypnotic Sleep Aid Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Apotex Hypnotic Sleep Aid Product Portfolio
- 4.17.5 Apotex Recent Developments
- 4.18 Alvogen
- 4.18.1 Alvogen Company Information
- 4.18.2 Alvogen Business Overview
- 4.18.3 Alvogen Hypnotic Sleep Aid Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Alvogen Hypnotic Sleep Aid Product Portfolio
- 4.18.5 Alvogen Recent Developments
- 4.19 Alembic Pharmaceuticals
- 4.19.1 Alembic Pharmaceuticals Company Information
- 4.19.2 Alembic Pharmaceuticals Business Overview
- 4.19.3 Alembic Pharmaceuticals Hypnotic Sleep Aid Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 Alembic Pharmaceuticals Hypnotic Sleep Aid Product Portfolio
- 4.19.5 Alembic Pharmaceuticals Recent Developments
- 4.20 Actavis
- 4.20.1 Actavis Company Information
- 4.20.2 Actavis Business Overview
- 4.20.3 Actavis Hypnotic Sleep Aid Sales, Revenue and Gross Margin (2021-2026)
- 4.20.4 Actavis Hypnotic Sleep Aid Product Portfolio
- 4.20.5 Actavis Recent Developments
5 Global Hypnotic Sleep Aid Market Scenario by Region
- 5.1 Global Hypnotic Sleep Aid Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Hypnotic Sleep Aid Sales by Region: 2021-2032
- 5.2.1 Global Hypnotic Sleep Aid Sales by Region: 2021-2026
- 5.2.2 Global Hypnotic Sleep Aid Sales by Region: 2027-2032
- 5.3 Global Hypnotic Sleep Aid Revenue by Region: 2021-2032
- 5.3.1 Global Hypnotic Sleep Aid Revenue by Region: 2021-2026
- 5.3.2 Global Hypnotic Sleep Aid Revenue by Region: 2027-2032
- 5.4 North America Hypnotic Sleep Aid Market Facts & Figures by Country
- 5.4.1 North America Hypnotic Sleep Aid Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Hypnotic Sleep Aid Sales by Country (2021-2032)
- 5.4.3 North America Hypnotic Sleep Aid Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Hypnotic Sleep Aid Market Facts & Figures by Country
- 5.5.1 Europe Hypnotic Sleep Aid Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Hypnotic Sleep Aid Sales by Country (2021-2032)
- 5.5.3 Europe Hypnotic Sleep Aid Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Hypnotic Sleep Aid Market Facts & Figures by Country
- 5.6.1 Asia Pacific Hypnotic Sleep Aid Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Hypnotic Sleep Aid Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Hypnotic Sleep Aid Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Hypnotic Sleep Aid Market Facts & Figures by Country
- 5.7.1 South America Hypnotic Sleep Aid Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Hypnotic Sleep Aid Sales by Country (2021-2032)
- 5.7.3 South America Hypnotic Sleep Aid Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Hypnotic Sleep Aid Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Hypnotic Sleep Aid Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Hypnotic Sleep Aid Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Hypnotic Sleep Aid Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Hypnotic Sleep Aid Sales by Type (2021-2032)
- 6.1.1 Global Hypnotic Sleep Aid Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Hypnotic Sleep Aid Sales Market Share by Type (2021-2032)
- 6.2 Global Hypnotic Sleep Aid Revenue by Type (2021-2032)
- 6.2.1 Global Hypnotic Sleep Aid Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Hypnotic Sleep Aid Revenue Market Share by Type (2021-2032)
- 6.3 Global Hypnotic Sleep Aid Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Hypnotic Sleep Aid Sales by Application (2021-2032)
- 7.1.1 Global Hypnotic Sleep Aid Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Hypnotic Sleep Aid Sales Market Share by Application (2021-2032)
- 7.2 Global Hypnotic Sleep Aid Revenue by Application (2021-2032)
- 7.2.1 Global Hypnotic Sleep Aid Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Hypnotic Sleep Aid Revenue Market Share by Application (2021-2032)
- 7.3 Global Hypnotic Sleep Aid Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Hypnotic Sleep Aid Value Chain Analysis
- 8.1.1 Hypnotic Sleep Aid Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Hypnotic Sleep Aid Production Mode & Process
- 8.2 Hypnotic Sleep Aid Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Hypnotic Sleep Aid Distributors
- 8.2.3 Hypnotic Sleep Aid Customers
9 Global Hypnotic Sleep Aid Analyzing Market Dynamics
- 9.1 Hypnotic Sleep Aid Industry Trends
- 9.2 Hypnotic Sleep Aid Industry Drivers
- 9.3 Hypnotic Sleep Aid Industry Opportunities and Challenges
- 9.4 Hypnotic Sleep Aid Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst